Table 3. Comparison of VCS progressors and non-progressors.

Parameter	Progressors (n = 34)	Non-progressors (n = 115)	P
Age (years)	63.15 ± 12.11	57.24 ± 12.9	0.019
Gender (male %)	61.8	51.3	0.283
Diabetes (%)	47.1	44.3	0.780
Cardiovascular
BMI (kg/m2)	22.19±2.41	22.85±3.64	0.224
Previous CVD (%)	38.2	32.2	0.511
Smoking habit (%)	41.2	40.9	0.974
Antihypertensive drugs (%)
RAS blockers	55.9	55.7	0.981
Beta-blockers	44.1	53	0.360
CCB	58.8	45.2	0.163
Anti-platelet agents (%)
Statins (%)	35.3	29.6	0.525
Ca-based P binder (%)	67.6	84.3	0.031
Vitamin D analogue (%)	26.5	27	0.955
HD
Dialysis duration (months) *	76 (64–108)	76 (61–121)	0.475
spKt/V	1.58 ± 0.20	1.59 ± 0.20	0.670
RAGE
Log S100A12 (ng/mL)	6.02 ± 0.85	5.63 ± 0.83	0.016
Log sRAGE (pg/mL)	7.54 ± 0.54	7.60 ± 0.67	0.612
Log IL-6 (pg/mL)	0.49 ± 0.69	0.65 ± 0.71	0.238
Laboratory (Time-averaged)
HDL-C (mg/dL)	40.5 ± 10.92	41.62 ± 11.85	0.624
LDL-C (mg/dL)	67.22 ± 16.53	64.36 ± 17.75	0.404
Albumin (g/L)	3.86 ± 0.33	3.88 ± 0.32	0.849
Hemoglobin (g/dL)	10.88 ± 0.73	10.93 ± 0.7	0.763
Ca (mg/dL)	8.77 ± 0.46	8.75 ± 0.49	0.879
P (mg/dL)	4.62 ± 0.78	4.57 ± 0.91	0.800
iPTH (pg/mL)	239.95 ± 244.33	270.71 ± 227.59	0.497
hsCRP (mg/dL)	1.3 ± 1.5	1.18 ± 1.26	0.643
25D (ng/mL)	11.66 ± 4.67	10.88 ± 3.37	0.280
1,25D (pg/mL)	18.01 ± 4.04	17.31 ± 3.96	0.369

Abbreviations: BMI, body mass index; CVD, cardiovascular disease; MAP, mean artery pressure; RAS, renin-angiotensin system; CCB, calcium channel blocker; Ca, calcium; spKt/V, single pool Kt/V;; sRAGE, soluble receptor for advanced glycation end product; IL-6, interleukin 6; HDL-C, HDL cholesterol; LDL-C, LDL cholesterol; TG, triglyceride; Ca, calcium; P, phosphorus;; iPTH, intact parathyroid hormone; hsCRP, highly sensitive C-reactive protein; 25D, 25-hydroxyvitamin D; 1,25D, 1,25-dihydroxyvitamin D

* Median, interquartile range